Lundbeck CEO Braestrup sees double-digit growth in 2007
Forbes - We have moved a depression treatment candidate to Phase II and bought a Phase III candidate (nalmefene).' Nalmefene is used in the treatment of substance and impulse control disorders. Late last month, Finland's BioTie Therapies Oyj granted Lundbeck
Source: www.forbes.com
Exclusive Reports
San Jose Business Journal - New leadership, new location for Parkinson's Institute Conflict of interest questions dog Reed's choice for budget czar Impact of patent ruling likely to extend far into tech sphere Corcept hopeful third test will clear depression treatment Buying
Source: sanjose.bizjournals.com
Click here for more information about beck depression inventory beck depression inventory
<< Home